Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma

Tae-Dong JEONG; Hyun-Sook CHI; Min-Sun KIM; Seongsoo JANG; Chan-Jeoung PARK; Joo-Ryung HUH.
Blood Research ; : 127-132, 2016.
Artículo en Inglés | WPRIM | ID: wpr-203294

Documentos relacionados

  1. Prognostic value and computer image analysis of p53 in mantle cell lymphoma.
  2. Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic.
  3. Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell Lymphoma.
  4. Mantle-Cell Lymphoma.
  5. Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
  6. MYC-induced cytidine metabolism regulates survival and drug resistance via cGas-STING pathway in mantle cell lymphoma.
  7. Twenty Years of Advancing Discoveries and Treatment of Mantle Cell Lymphoma.
  8. Update on mantle cell lymphoma.
  9. Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma.
  10. NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.